» Articles » PMID: 30685876

Ataxia-telangiectasia: A Review of Clinical Features and Molecular Pathology

Overview
Specialty Pediatrics
Date 2019 Jan 28
PMID 30685876
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Ataxia-telangiectasia (A-T) is an autosomal recessive primary immunodeficiency (PID) disease that is caused by mutations in ataxia-telangiectasia mutated (ATM) gene encoding a serine/threonine protein kinase. A-T patients represent a broad range of clinical manifestations including progressive cerebellar ataxia, oculocutaneous telangiectasia, variable immunodeficiency, radiosensitivity, susceptibility to malignancies, and increased metabolic diseases. This congenital disorder has phenotypic heterogeneity, and the severity of symptoms varies in different patients based on severity of mutations and disease progression. The principal role of nuclear ATM is the coordination of cellular signaling pathways in response to DNA double-strand breaks, oxidative stress, and cell cycle checkpoint. The pathogenesis of A-T is not limited to the role of ATM in the DNA damage response (DDR) pathway, and it has other functions mainly in the hematopoietic cells and neurons. ATM adjusts the functions of organelles such as mitochondria and peroxisomes and also regulates angiogenesis and glucose metabolisms. However, ATM has other functions in the cells (especially cell viability) that need further investigations. In this review, we described functions of ATM in the nucleus and cytoplasm, and also its association with some disorder formation such as neurologic, immunologic, vascular, pulmonary, metabolic, and dermatologic complications.

Citing Articles

Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile.

Viart N, Renault A, Eon-Marchais S, Jiao Y, Fuhrmann L, El Houdigui S Breast Cancer Res. 2025; 27(1):36.

PMID: 40069712 PMC: 11899765. DOI: 10.1186/s13058-025-01988-w.


Evaluation of T-cell repertoire by flow cytometric analysis in primary immunodeficiencies with DNA repair defects.

Karaaslan B, Demirkale Z, Turan I, Aydemir S, Meric Z, Taskin Z Scand J Immunol. 2025; 101(2):e70003.

PMID: 39967281 PMC: 11836546. DOI: 10.1111/sji.70003.


Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasia.

Koenig M, Leuzzi V, Gouider R, Yiu E, Pietrucha B, Stray-Pedersen A Front Neurol. 2025; 15:1526914.

PMID: 39917433 PMC: 11800360. DOI: 10.3389/fneur.2024.1526914.


The cGAS-STING, p38 MAPK, and p53 pathways link genome instability to accelerated cellular senescence in ATM-deficient murine lung fibroblasts.

Haj M, Frey Y, Levon A, Maliah A, Ben-Yishay T, Slutsky R Proc Natl Acad Sci U S A. 2025; 122(2):e2419196122.

PMID: 39772747 PMC: 11745328. DOI: 10.1073/pnas.2419196122.


Novel pathogenic ATM mutation with ataxia-telangiectasia in a Chinese family.

Zhou Q, Chen M, Tao E Front Genet. 2024; 15:1491649.

PMID: 39678378 PMC: 11638744. DOI: 10.3389/fgene.2024.1491649.